NWBO
Northwest Biotherapeutics, Inc. Common stock
NWBO
NWBO
Delisted
NWBO was delisted on the 16th of December, 2016.
7 hedge funds and large institutions have $42K invested in Northwest Biotherapeutics, Inc. Common stock in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
OCG
1
Opus Capital Group
Cincinnati,
Ohio
|
$3K |
| 2 |
WPP
2
Whalerock Point Partners
Providence,
Rhode Island
|
$16K |
Top Sellers
| 1 |
1
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
$2K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
WPP
1
Whalerock Point Partners
Providence,
Rhode Island
| $16K | 60,000 | +9,000 | +18% |
|
|
SAM
2
Seelaus Asset Management
Chatham,
New Jersey
| $13K | 50,000 | – | – |
|
|
LDB
3
Lee, Danner & Bass
Nashville,
Tennessee
| $5K | 20,000 | – | – |
|
|
MPI
4
Mairs & Power Inc
St Paul,
Minnesota
| $3K | 12,500 | – | – |
|
|
OCG
5
Opus Capital Group
Cincinnati,
Ohio
| $3K | 10,000 | +10,000 | New |
|
|
6
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $2K | 6,000 | -3,200 | -35% |
|
|
CFG
7
Citizens Financial Group
Providence,
Rhode Island
| $0 | 625 | +625 | New |
|